NCI Community Oncology Research Program (NCORP)

The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.

The DCP Community Oncology and Prevention Trials Research Group administers this program.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

About NCORP

The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

Visit the NCORP Website

Grantee Details

No matching Grants were found.

View All Grants

Clinical Trials

Status
Title Sort descending Intervention Sponsor Status
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Text message reminder SWOG Cancer Research Network Completed
S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer acupuncture therapy, sham acupuncture SWOG Cancer Research Network Completed
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy duloxetine hydrochloride, placebo SWOG Cancer Research Network Completed
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction gastrointestinal complications management/prevention, quality-of-life assessment, therapeutic conventional surgery SWOG Cancer Research Network Completed
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration SWOG Cancer Research Network Completed
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Quality-of-Life Assessment, Questionnaire Administration SWOG Cancer Research Network Completed
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer Carvedilol, Laboratory Biomarker Analysis, Patient Observation SWOG Cancer Research Network Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring SWOG Cancer Research Network Recruiting
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia Best Practice, Laboratory Biomarker Analysis, Supportive Care ECOG-ACRIN Cancer Research Group Active, not recruiting
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Standard radiation therapy, intensity-modulated radiation therapy Radiation Therapy Oncology Group Completed

News and Events